Immix Biopharma, Inc.
Status: Publicly traded
Direct answer
Immix Biopharma, Inc. is publicly traded on NASDAQ under the ticker IMMX.
Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They...
Can you invest in Immix Biopharma, Inc.?
Yes. Immix Biopharma, Inc. trades publicly on NASDAQ as IMMX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Immix Biopharma, Inc.
Detailed equity research is provided by MarketSnap.